Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE
995.40
+7.3(+0.74%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
995.40
+7.3(+0.74%)
Currency In INR
| Market Cap | 145.64B |
| Enterprise Value | 162.07B |
| P/E Ratio | 36.44 |
| PEG Ratio | -1.18 |
| Price/Sales Ratio | 1.99 |
| Price/Book Ratio | 2.39 |
| Enterprise/Revenue | 2.28 |
| Enterprise/EBITDA | 14.91 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.05 |
| Operating Margin | 0.19 |
| Return On Assets | 0.03 |
| Return On Equity | 0.07 |
| Revenue | 72.35B |
| Revenue/Share | 499.91 |
| Gross Profit | 46.99B |
| EBITDA | 10.48B |
| Net Income | 8.39B |
| Diluted EPS | 52.85 |
| Total Cash | 6.23B |
| Total Cash/Share | 39.34 |
| Total Debt | 28.83B |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.66 |
| Book Value Per Share | 414.89 |
| 52-Week Change | 9.74 |
| 52-Week High | 1,248 |
| 52-Week Low | 786.05 |
| Moving Average 50 Days | 882.59 |
| Moving Average 200 Days | 1,015.94 |
| Average Volume | 158,639 |
| Shares Outstanding | 158.39M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.5 |
| Payout Ratio | 0.18 |
| Last Split Factor | 21:20 |
| Last Split Date | November 25, 2010 |